Adaptin Bio (APTN) Operating Expenses (2023 - 2026)
Adaptin Bio (APTN) posted Operating Expenses of $1.1 million for Q1 2026, down 16.36% sequentially from $1.4 million in Q4 2025, and up 34.53% YoY from $850458.0 in Q1 2025.
Adaptin Bio (APTN) Operating Expenses (2023 - 2026) Analysis & Trends
Adaptin Bio has reported Operating Expenses for 4 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Operating Expenses rose 34.53% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (up 82.93% YoY) and the FY2025 annual result came in at $5.4 million, up 110.71% from the prior year.
- Operating Expenses fell to $1.1 million in Q1 2026 per APTN's latest filing, from $1.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $1.7 million in Q3 2025 and troughed at $34155.0 in Q4 2023.
- A 4-year average of $836915.8 and a median of $850458.0 in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2026: Operating Expenses jumped 2216.71% in 2024, then surged 34.53% in 2026.
- Over 4 years, Operating Expenses stood at $34155.0 in 2023, then surged by 1387.57% to $508080.0 in 2024, then soared by 169.25% to $1.4 million in 2025, then dropped by 16.36% to $1.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.1 million, $1.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 850,458.00 |
| Dec 31, 2024 | 508,080.00 |
| Sep 30, 2024 | 994,749.00 |
| Jun 30, 2024 | 767,320.00 |
| Mar 31, 2024 | 299,736.00 |
| Dec 31, 2023 | 34,155.00 |
| Sep 30, 2023 | 42,938.00 |